Journal articles on the topic 'Multiple myeloma Chemotherapy'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Multiple myeloma Chemotherapy.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Durie, Brian G. M. "Chemotherapy of multiple myeloma." Baillière's Clinical Haematology 4, no. 1 (January 1991): 181–95. http://dx.doi.org/10.1016/s0950-3536(05)80290-2.
Kogan, Michael, and Adnan H. Siddiqui. "Intracranial Multiple Myeloma After Chemotherapy." Archives of Clinical and Medical Case Reports 01, no. 02 (2017): 42–44. http://dx.doi.org/10.26502/acmcr.9655008.
Lokhorst, H. M., O. J. A. Th Meuwissen, E. J. E. G. Bast, and A. W. Dekker. "VAD chemotherapy for refractory multiple myeloma." British Journal of Haematology 71, no. 1 (January 1989): 25–30. http://dx.doi.org/10.1111/j.1365-2141.1989.tb06269.x.
Peest, D., H. J. Schmoll, I. Schedel, S. Glück, K. Schumacher, and H. Deicher. "VBAMDex chemotherapy in advanced multiple myeloma*." European Journal of Haematology 40, no. 3 (April 24, 2009): 245–49. http://dx.doi.org/10.1111/j.1600-0609.1988.tb00831.x.
Terrovitis, John V., Charis Matsouka, Athanassios Anagnostopoulos, Maria I. Anastasiou-Nana, and Athanassios Meletios Dimopoulos. "Hemophagocytic Lymphohistiocytosis After Chemotherapy for Multiple Myeloma." Clinical Lymphoma 5, no. 3 (December 2004): 194–96. http://dx.doi.org/10.3816/clm.2004.n.026.
Alexanian, Raymond, Bart Barlogie, and Gerard Ventura. "Chemotherapy for resistant and relapsing multiple myeloma." European Journal of Haematology 43, S51 (April 24, 2009): 140–44. http://dx.doi.org/10.1111/j.1600-0609.1989.tb01507.x.
Vidarsson, Brynjar, Svanhvit Olafsdottir, and Sigrun Reykdal. "VASP Chemotherapy in Patients with Multiple Myeloma." Blood 106, no. 11 (November 16, 2005): 5189. http://dx.doi.org/10.1182/blood.v106.11.5189.5189.
Minařík, Jiří, and Sabina Ševčíková. "Immunomodulatory Agents for Multiple Myeloma." Cancers 14, no. 23 (November 23, 2022): 5759. http://dx.doi.org/10.3390/cancers14235759.
Katagiri, Daisuke, Eisei Noiri, and Fumihiko Hinoshita. "Multiple Myeloma and Kidney Disease." Scientific World Journal 2013 (2013): 1–9. http://dx.doi.org/10.1155/2013/487285.
Bensinger, William I. "Hematopoietic Cell Transplantation for Multiple Myeloma." Cancer Control 5, no. 3 (May 1998): 235–42. http://dx.doi.org/10.1177/107327489800500304.
&NA;. "High-dose chemotherapy + stem cells for multiple myeloma." Inpharma Weekly &NA;, no. 1387 (May 2003): 13. http://dx.doi.org/10.2165/00128413-200313870-00036.
Rohatgi, Nidhi, Xianglin L. Du, Ann L. Coker, Lemuel A. Moye, Michael Wang, and Shenying Fang. "Chemotherapy and Survival for Patients With Multiple Myeloma." American Journal of Clinical Oncology 30, no. 5 (October 2007): 540–48. http://dx.doi.org/10.1097/coc.0b013e3180592a30.
Anderson, H., JH Scarffe, M. Ranson, R. Young, GS Wieringa, GR Morgenstern, L. Fitzsimmons, and D. Ryder. "VAD chemotherapy as remission induction for multiple myeloma." British Journal of Cancer 71, no. 2 (February 1995): 326–30. http://dx.doi.org/10.1038/bjc.1995.65.
Puri, Sonam, Jitesh Joshi, Olga Derman, Noah Kornblum, Amit Verma, Ira Braunschweig, and Ramakrishna Battini. "Ocular Complications of Bortezomib Therapy in Multiple Myeloma." Blood 124, no. 21 (December 6, 2014): 5743. http://dx.doi.org/10.1182/blood.v124.21.5743.5743.
Kristinsson, Sigurdur Yngvi. "Thrombosis in Multiple Myeloma." Hematology 2010, no. 1 (December 4, 2010): 437–44. http://dx.doi.org/10.1182/asheducation-2010.1.437.
Chng, Wee Joo, Lee Gong Lau, Noorainun Yusof, and Benjamin M. F. Mow. "Targeted Therapy in Multiple Myeloma." Cancer Control 12, no. 2 (April 2005): 91–104. http://dx.doi.org/10.1177/107327480501200204.
Lonial, Sagar. "Relapsed Multiple Myeloma." Hematology 2010, no. 1 (December 4, 2010): 303–9. http://dx.doi.org/10.1182/asheducation-2010.1.303.
Li, Juan, Junhe Li, Shaokai Luo, and Yin Zhao. "Expression of TRAIL Receptors on the Multiple Myeloma Cells." Blood 104, no. 11 (November 16, 2004): 4868. http://dx.doi.org/10.1182/blood.v104.11.4868.4868.
Luca, Dragos C., and Imad Y. Almanaseer. "Simultaneous Presentation of Multiple Myeloma and Acute Monocytic Leukemia." Archives of Pathology & Laboratory Medicine 127, no. 11 (November 1, 2003): 1506–8. http://dx.doi.org/10.5858/2003-127-1506-spomma.
Tu, Yong-sheng, Jin He, Huan Liu, Richard Eric Davis, Robert Z. Orlowski, Joshua E. Allen, and Jing Yang. "ONC201 Overcomes Chemotherapy Resistance By Upregulation of Bim in Multiple Myeloma." Blood 128, no. 22 (December 2, 2016): 4476. http://dx.doi.org/10.1182/blood.v128.22.4476.4476.
Mohamed, Muhajir, and Karen Dun. "Complex hypodiploid acute myeloid leukaemia secondary to chemotherapy for hyperdiploid multiple myeloma." International Journal of Hematology 100, no. 1 (May 13, 2014): 3–6. http://dx.doi.org/10.1007/s12185-014-1594-y.
Huff, Carol Ann, and William Matsui. "Multiple Myeloma Cancer Stem Cells." Journal of Clinical Oncology 26, no. 17 (June 10, 2008): 2895–900. http://dx.doi.org/10.1200/jco.2007.15.8428.
Todaro, Juliana, Patrícia Weinschenker Bollmann, Amit Nussbacher, Luis Fernando Aranha Camargo, Bento Fortunato Cardoso dos Santos, Daniel Alvarenga, Laercio Alberto Rosemberg, David Costa de Souza Le Bihan, Cláudio Henrique Fischer, and Auro del Giglio. "Multiple myeloma complicated with pseudomonas endocartiditis." Einstein (São Paulo) 10, no. 4 (December 2012): 498–501. http://dx.doi.org/10.1590/s1679-45082012000400017.
Chandran, Rekha, Miklos Simon, and Stephen E. Spurgeon. "Concurrent Presentation of Hodgkin Lymphoma and Multiple Myeloma." Case Reports in Hematology 2013 (2013): 1–3. http://dx.doi.org/10.1155/2013/398769.
Berneman, Zwi N., An-Sofie Verstraete, Alain Gadisseur, Ann Van de Velde, and Wilfried A. Schroyens. "The Survival of Multiple Myeloma Patients: A Single Institution Study." Blood 104, no. 11 (November 16, 2004): 5223. http://dx.doi.org/10.1182/blood.v104.11.5223.5223.
Kaneko, Haruo, Ken Shikoshi, Shuichi Annou, Masashi Takada, Motoharu Kato, Setsuro Moro, Mikio Yamauchi, and Tatsuo Shirai. "VCAP Combination Chemotherapy for Multiple Myeloma in the Aged." Nippon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics 28, no. 4 (1991): 504–8. http://dx.doi.org/10.3143/geriatrics.28.504.
Johnstone, Megan, Delaney Vinaixa, Marcello Turi, Eugenio Morelli, Kenneth Carl Anderson, and Annamaria Gulla. "Promises and Challenges of Immunogenic Chemotherapy in Multiple Myeloma." Cells 11, no. 16 (August 14, 2022): 2519. http://dx.doi.org/10.3390/cells11162519.
Ii, Frederick Richards, Morton Coleman, M. Robert Cooper, and W. Perry Ballard. "Multiple Myeloma—Complete Remission with High Dose Melphalan Chemotherapy." Cancer Investigation 3, no. 1 (January 1985): 15–21. http://dx.doi.org/10.3109/07357908509040604.
Wright, A., S. Elkins, J. Files, C. Bigelow, V. Herrin, and M. Sample. "THROMBOEMBOLISM IN MULTIPLE MYELOMA PATIENTS RECEIVING THALIDOMIDE COMBINATION CHEMOTHERAPY." Journal of Investigative Medicine 55, no. 1 (January 2007): S302. http://dx.doi.org/10.1097/00042871-200701010-00839.
Ucci, G., A. Riccardi, P. Dörmer, M. Danova, and R. Luoni. "Early Plasma Cell Recruitment In Multiple Myeloma Following Chemotherapy." Cell Proliferation 21, no. 6 (November 1988): 405–9. http://dx.doi.org/10.1111/j.1365-2184.1988.tb00800.x.
Palva, I. P., P. Ahrenberg, A. Almquist, K. Ala-Harja, J. Apajalahti, H. Hallman, A. Hänninen, et al. "Aggressive combination chemotherapy in multiple myeloma. A multicentre trial." Scandinavian Journal of Haematology 35, no. 2 (April 24, 2009): 205–9. http://dx.doi.org/10.1111/j.1600-0609.1985.tb01574.x.
Palva, I. P. "Combination chemotherapy MOCCA in resistant and relapsing multiple myeloma." European Journal of Haematology 48, no. 1 (April 24, 2009): 37–40. http://dx.doi.org/10.1111/j.1600-0609.1992.tb01791.x.
Fassas, Athanasios B. T., Trey Spencer, Raman Desikan, Maurizio Zangari, Elias Anaissie, Bart Barlogie, and Guido Tricot. "Cytotoxic chemotherapy following tandem autotransplants in multiple myeloma patients." British Journal of Haematology 119, no. 1 (October 2002): 164–68. http://dx.doi.org/10.1046/j.1365-2141.2002.03772.x.
SWAN, GEORGE W. "Optimal Control Applications in the Chemotherapy of Multiple Myeloma." Mathematical Medicine and Biology 2, no. 3 (1985): 139–60. http://dx.doi.org/10.1093/imammb/2.3.139.
Zhan, Fenghuang, Wen Zhou, Maurizio Zangari, Hongwei Xu, and Guido J. Tricot. "ALDH1 Activity Identifies Chemotherapy-Resistant Multiple Myeloma Stem Cells." Blood 118, no. 21 (November 18, 2011): 990. http://dx.doi.org/10.1182/blood.v118.21.990.990.
Becker, Pamela S. "Genetic Predisposition for Chemotherapy-Induced Neuropathy in Multiple Myeloma." Journal of Clinical Oncology 29, no. 7 (March 1, 2011): 783–86. http://dx.doi.org/10.1200/jco.2010.33.4771.
Song, Yan, Ning Hu, Xiaowei Song, and Juhong Yang. "Hsa_Circ_0007841 Enhances Multiple Myeloma Chemotherapy Resistance Through Upregulating ABCG2." Technology in Cancer Research & Treatment 19 (January 1, 2020): 153303382092837. http://dx.doi.org/10.1177/1533033820928371.
Kryukov, E. V., V. N. Troyan, O. A. Rukavitsyn, S. V. Kozyrev, I. G. Daragan-Sushchov, V. P. Pop, S. A. Alekseev, and E. R. Sapelnikova. "Densitometry as a monitoring method in the treatment of patients with multiple myeloma." Medical Visualization, no. 5 (October 28, 2018): 106–13. http://dx.doi.org/10.24835/1607-0763-2018-5-106-113.
Sinclair, David, Adel Resouly, and Anne Spedding. "Stridor: unusual presentation of multiple myeloma." Journal of Laryngology & Otology 117, no. 10 (October 2003): 829–31. http://dx.doi.org/10.1258/002221503770716313.
Israelyan, E. R., C. S. Golovataya, O. K. Bondarenko, A. V. Nayda, and A. K. Pudeeva. "Onset of multiple myeloma with rheumatic polymyalgia." Medical Herald of the South of Russia 10, no. 4 (December 26, 2019): 98–104. http://dx.doi.org/10.21886/2219-8075-2019-10-4-98-104.
Palva, I. P., K. Ala-Harja, A. Almqvist, E. Elonen, H. Hallman, A. Hänninen, M. Ilvonen, et al. "Corticosteroid is not beneficial in multiple-drug combination chemotherapy for multiple myeloma." European Journal of Haematology 51, no. 2 (April 24, 2009): 98–101. http://dx.doi.org/10.1111/j.1600-0609.1993.tb01600.x.
Salmon, S. E., J. J. Crowley, T. M. Grogan, P. Finley, R. P. Pugh, and B. Barlogie. "Combination chemotherapy, glucocorticoids, and interferon alfa in the treatment of multiple myeloma: a Southwest Oncology Group study." Journal of Clinical Oncology 12, no. 11 (November 1994): 2405–14. http://dx.doi.org/10.1200/jco.1994.12.11.2405.
Coss, Alan, Chen Zhou, Michael F. Byrne, and Alan A. Weiss. "Relapse of Multiple Myeloma Presenting with Biliary Obstruction." Canadian Journal of Gastroenterology 24, no. 4 (2010): 237–38. http://dx.doi.org/10.1155/2010/593859.
Sawicki, C. P., S. A. Climans, C. C. Hsia, and J. A. Fraser. "Progressive multifocal leukoencephalopathy during ixazomib-based chemotherapy." Current Oncology 25, no. 1 (February 28, 2018): 99. http://dx.doi.org/10.3747/co.25.3674.
Haegelen, Claire, Laurent Riffaud, Marc Bernard, Beatrice Carsin-Nicol, and Xavier Morandi. "Dural plasmacytoma revealing multiple myeloma." Journal of Neurosurgery 104, no. 4 (April 2006): 608–10. http://dx.doi.org/10.3171/jns.2006.104.4.608.
Sampat, Parth J., Maneesh Bisen, Nimisha Srivastava, Suman Rao, and Teresa Gentile. "Accidental Ixazomib Overdose in a Patient With Multiple Myeloma." Journal of Investigative Medicine High Impact Case Reports 9 (January 2021): 232470962110132. http://dx.doi.org/10.1177/23247096211013230.
Rathnakumar, Geeta, Kinjalka Ghosh, Nikhil Choudhary, Narendra Kamble, and Nitin Inamdar. "Study of prognostic factors in multiple myeloma." International Journal of Advances in Medicine 8, no. 11 (October 26, 2021): 1694. http://dx.doi.org/10.18203/2349-3933.ijam20214131.
Quesada, JR, R. Alexanian, M. Hawkins, B. Barlogie, E. Borden, L. Itri, and JU Gutterman. "Treatment of multiple myeloma with recombinant alpha-interferon." Blood 67, no. 2 (February 1, 1986): 275–78. http://dx.doi.org/10.1182/blood.v67.2.275.275.
Quesada, JR, R. Alexanian, M. Hawkins, B. Barlogie, E. Borden, L. Itri, and JU Gutterman. "Treatment of multiple myeloma with recombinant alpha-interferon." Blood 67, no. 2 (February 1, 1986): 275–78. http://dx.doi.org/10.1182/blood.v67.2.275.bloodjournal672275.
Ostrovskyi, V. L., I. M. Skrypnyk, G. S. Maslova, O. A. Shaposhnyk, and L. I. Yakymyshyna. "PECULIARITIES OF MYOCARDIAL BIOELECTRIC ACTIVITY IN PATIENTS WITH PROGRESSIVE MYLTIPLE MYELOMA RECEIVING BORTEZOMIB-CONTAINING CHEMOTHERAPY SCHEMES." Актуальні проблеми сучасної медицини: Вісник Української медичної стоматологічної академії 22, no. 3-4 (November 29, 2022): 80–84. http://dx.doi.org/10.31718/2077-1096.22.3.4.80.